MAP 2022 — MOLECULAR ANALYSIS FOR PRECISION ONCOLOGY CONGRESS 2022

MAP is the leading global meeting dedicated to precision oncology, defined as molecular profiling of tumours to identify targetable alterations. This oncology field is fast evolving and has now entered the mainstream of clinical practice.

At MAP 2022, international key opinion leaders will explain how to use genomic data for treating cancer patients, matching such data to a specific drug or therapy, based on the genetic drivers detected in the patients’ tumours, and they will debate about the future challenges in precision oncology.

Topics: cancer biology, translational research, molecular pathology, clinical research, immunotherapy, personalised cancer medicine, precision medicine, tumour immunology, anticancer agents, basic science, biological therapy, laboratory medicine, genetic counselling, tumour response evaluation, imaging, molecular imaging